The unique KEGG pathway in CH indicates that changes in the p53 pathway accompanied by the activation of the RhoA/Rho kinase signaling pathway, may trigger compensatory myocardial hypertrophy of the LV thereby maintaining cardiac structure and contraction. The gene discussed is RHOA; the disease is cardiac hypertrophy.